PRINCETON, N.J., Sept. 17 /PRNewswire/ -- The NeoStrata Company, Inc. announced today the appointment of Peter Crisafulli to the position of Vice President of Operations. In his new role, Mr. Crisafulli will support the continued growth of NeoStrata's existing brands, both domestically and in more than 70 countries around the world.
"I'm thrilled to be joining the wonderful people of NeoStrata at this exciting time in the company's life," said Mr. Crisafulli, "I look forward to helping them meet all their growth needs across all their markets."
Mr. Crisafulli joins The NeoStrata Company, Inc. with many years of senior management experience in the pharmaceutical and personal care industries. Most recently, he had been consulting for Johnson & Johnson. Previously, he spent fourteen years in ever increasing operation positions at Revlon rising to be their Vice President of International Operations. His prior experience also includes sixteen years with Ciba-Geigy, including time as their Vice President of Manufacturing. Mr. Crisafulli brings a strong track record of manufacturing and operational excellence which should truly help facilitate NeoStrata's domestic and international growth.
Mr. Crisafulli holds a B.S. degree in Industrial Engineering from the New Jersey Institute of Technology, and an MBA from Seton Hall University.
About The NeoStrata Company, Inc.
The NeoStrata Company is a privately held, research-based company located in Princeton, New Jersey. It was founded in 1988 by leading dermatological researchers and inventors, Ruey J.Yu, Ph.D., O.M.D., and dermatologist Eugene J. Van Scott, M.D., who are widely recognized as the pioneers of alpha-hydroxy acid (AHA) technology. Today, NeoStrata continues to develop and to license its extensive portfolio of patented technology including polyhydroxy acids (PHAs) and the bionic acids, as well as novel N-acetyl amino sugars and N-acetyl amino acids for cosmetic, OTC and Rx applications. NeoStrata also markets globally its own comprehensive lines of skincare brands, including NeoStrata, Exuviance and CoverBlend; and, has recently initiated its first clinical studies for prescription dermatologicals.
|SOURCE The NeoStrata Company, Inc.|
Copyright©2007 PR Newswire.
All rights reserved